UPDATE: Goldman Sachs Downgrades Lyell Immunopharma (LYEL) to Neutral
Tweet Send to a Friend
(Updated - November 11, 2022 9:31 AM EST)
Goldman Sachs analyst Salveen Richter downgraded Lyell Immunopharma (NASDAQ: LYEL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter downgraded Lyell Immunopharma (NASDAQ: LYEL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
